Skip to content

NATRELLE 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants ML-410170Recalls & reported problems

Allergan, Inc. · STYLE 410, ML, 170G BIOCELL |textured|contour|silicone · Class 3 · Implant

All models of Natrelle Breast Implants (1167)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
1

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10888628003545), received between Oct 13, 2021 and Oct 13, 2021 — classified as 1 injury.

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. Jul 24, 2019Class IOpen, Classified

    The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.

    Z-2452-2019 · Root cause: Unknown/Undetermined by firm · Recall details · FDA record ↗

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA ALCL)1
  • Seroma1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 13, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    HEALTHCARE PROFESSIONAL REPORTED RIGHT SIDE ¿EXCHANGE OF TEXTURED DEVICE DUE TO PATIENT'S CONCERN WITH PRODUCT¿ AND ULTRASOUND GUIDED ASPIRATION YIELDING ¿SEROMA FLUID (20 ML), POSITIVE LAB FOR BIA-ALCL;" MARKERS OF CD30+ AND ALK- HAVE BEEN REPORTED AND CONFIRMED. THE DEVICE HAS BEEN EXPLANTED; CAPSULECTOMY PERFORMED.

    Patient problems: Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA ALCL); Seroma

    MAUDE report 12626056 ↗

Other Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled devices

All Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page